BioSpace News Archive

Anima Biotech today announced an agreement with Lilly for the discovery and development of translation inhibitors.

CytRx Corporation today announced the expiration of warrants for approximately 3.2 million shares of its common stock, effective July 20, 2018.

Second Genome today announced the appointment of Anupama S. Hoey as chief business officer. In her role, Ms. Hoey will be leading all corporate development activities and strategic alliance opportunities for the company.

Azafaros, today announced the closing of a seed financing round. BioGeneration Ventures (BGV) is the founding investor.

Biologics, Inc., a McKesson Specialty Health oncology, neurology and complex care pharmacy services company, has been selected by Agios Pharmaceuticals, Inc. to be in the limited distribution network for TIBSOVO® (ivosidenib), an IDH1 inhibitor approved by the FDA for the treatment of adult patients with relapsed/refractory...

Medicine-On-Time, LLC (Medicine-On-Time) announced today the release of three new medication management products.

Agency responds to citizen petition, announces agreements with universities, updates bulks categories and schedules advisory committee meeting

Teva’s Copaxone remains the brand share leader among new start patients year-over-year, although neurologists are beginning to write prescriptions for Mylan’s generic glatiramer acetate and Sandoz’s Glatopa independent of direct payer influence, according to a recently published independent audit from Spherix Global Insights

Once combined, the two entities will create one of the five largest Catholic health care systems in the nation, with more than 57,000 employees and 1,000 sites of care

Pulmatrix Inc., (NASDAQ: PULM), a clinical stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary diseases announced today the formation of the Clinical Advisory Board (CAB) for Pulmazole (PUR1900) - an inhaled iSPERSE™ formulation of the anti-fungal drug itraconazole for the treatment of allergic bronchopulmonary aspergillosis (ABPA) in patients with asthma.